- Volume is elevated versus the 13-week average, confirming attention.
ODI
STO
Week ended 07 Aug 2026
Weekly Investor Report
ODI Pharma AB · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
2.72 SEK
17.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -19.8% below the Trend Line and sits at 38.7% of its 52-week range. The latest completed week returned 17.2%, after a 18.3% four-week move. The latest news-sentiment score is 50/100.
Setup score
38
out of 100
Latest Close
2.72 SEK
7 Aug 2026
1W Return
17.2%
latest completed week
4W Return
18.3%
short-term follow-through
12W Return
-28.8%
quarterly tape
Trend Breadth
44.2%
23 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
17.2%
Latest completed week; four-week move 18.3%.
Indicator stack
24/29
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.90%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -19.8% below the Trend Line and sits at 38.7% of its 52-week range. The latest completed week returned 17.2%, after a 18.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1612-week average 0.48
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 18.3% over four weeks, -28.8% over 12 weeks, and 78.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year23
Trend breadth44.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.20Latest activity-pressure read.
Pressure change12.5%Four-week change in activity pressure.
Leadership-10.80Latest relative-leadership reading.
RS change47.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-50.1%Distance below the 52-week high.
13-week volatility9.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2613 weeks finished lower.
Best week+19.6%Week of 24 Apr.
Worst week-18.6%Week of 5 Jun.
Latest week+17.2%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks1
Modest losses5
Sharp losses8
Recent vol9.6%13-week weekly-return volatility.
Base vol19.6%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew14.5% / -7.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank- / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Drug Manufacturers - Specialty & Generic
4-week rank3 / 19
Group average1.8%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD36.8%positive activity pressure
RS21.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape32/100
Trend, activity pressure, participation, and risk combine to a 32/100 tape read.
Indicator analysis20/100Latest 12-week confirmation: trend 2/12, activity pressure 0/12, relative leadership 3/12.
Activity pressure 0.16; No reversal markers Next-Week ExpectancyNegative 42.90%Next-week expectancy is negative with a 42.90% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2.72 SEK | 17.2% | 3.39 SEK | 3.80 SEK | -1.20 | -10.80 | 41.5K | Off |
| 31 Jul 2026 | 2.32 SEK | 1.8% | 3.43 SEK | 3.82 SEK | -1.35 | -22.00 | 4.8K | Off |
| 24 Jul 2026 | 2.28 SEK | -0.9% | 3.49 SEK | 3.84 SEK | -1.36 | -22.10 | 17.3K | Off |
| 17 Jul 2026 | 2.30 SEK | 0.0% | 3.53 SEK | 3.86 SEK | -1.39 | -19.86 | 25.9K | Off |
| 10 Jul 2026 | 2.30 SEK | 2.7% | 3.57 SEK | 3.88 SEK | -1.37 | -20.73 | 9.3K | Off |
| 3 Jul 2026 | 2.24 SEK | -12.5% | 3.55 SEK | 3.90 SEK | -1.37 | -25.09 | 175 | Off |
| 26 Jun 2026 | 2.56 SEK | -4.5% | 3.53 SEK | 3.91 SEK | -1.33 | -11.83 | 9.6K | Off |
| 19 Jun 2026 | 2.68 SEK | -10.7% | 3.50 SEK | 3.93 SEK | -1.18 | -8.48 | 51.2K | Off |
| 12 Jun 2026 | 3.00 SEK | 10.3% | 3.45 SEK | 3.94 SEK | -1.01 | 4.49 | 90 | Off |
| 5 Jun 2026 | 2.72 SEK | -18.6% | 3.39 SEK | 3.95 SEK | -0.81 | -5.05 | 28.1K | Off |
| 29 May 2026 | 3.34 SEK | -13.9% | 3.35 SEK | 3.97 SEK | -0.59 | 16.07 | 56.9K | On |
| 22 May 2026 | 3.88 SEK | 1.6% | 3.28 SEK | 3.98 SEK | -0.32 | 35.22 | 6.4K | On |
| 15 May 2026 | 3.82 SEK | 2.7% | 3.20 SEK | 3.99 SEK | -0.05 | 38.50 | 21.5K | On |
| 8 May 2026 | 3.72 SEK | -14.3% | 3.12 SEK | 4.00 SEK | -0.05 | 34.58 | 81.0K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.